oxybutynin has been researched along with Anticholinergic Syndrome in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Anticholinergic Syndrome: Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.
Excerpt | Relevance | Reference |
---|---|---|
"Physostigmine functions as a reversible acetylcholinesterase inhibitor that readily crosses the blood-brain barrier." | 5.91 | Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report. ( Fratta, KA; Ginder, M; Haggerty, DA, 2023) |
"Physostigmine functions as a reversible acetylcholinesterase inhibitor that readily crosses the blood-brain barrier." | 1.91 | Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report. ( Fratta, KA; Ginder, M; Haggerty, DA, 2023) |
" WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Although therapeutically dosed scopolamine transdermal patches rarely cause complications, incomplete toxidromes can be insidiously common in polypharmacy settings." | 1.46 | Postoperative Anticholinergic Poisoning: Concealed Complications of a Commonly Used Medication. ( Farrell, N; Hack, J; Haronian, T; Zhang, XC, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fratta, KA | 1 |
Ginder, M | 1 |
Haggerty, DA | 1 |
Zhang, XC | 1 |
Farrell, N | 1 |
Haronian, T | 1 |
Hack, J | 1 |
2 other studies available for oxybutynin and Anticholinergic Syndrome
Article | Year |
---|---|
Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
Topics: Acetylcholinesterase; Anticholinergic Syndrome; Antidotes; Cholinergic Antagonists; Cholinesterase I | 2023 |
Postoperative Anticholinergic Poisoning: Concealed Complications of a Commonly Used Medication.
Topics: Anticholinergic Syndrome; Cholinergic Antagonists; Dystonia; Emergency Service, Hospital; Female; Ha | 2017 |